BRANDI DANIEL: Open Payments
NPI 1437478948 · LAGRANGE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,738 in 94 payments from 22 companies in 2025. Trend: 2023 $1,579 · 2024 $1,813 · 2025 $1,738
Food & beverage: $1,738
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $391 |
| Ardelyx, Inc. | 14 | $287 |
| Janssen Biotech, Inc. | 6 | $126 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $109 |
| Medtronic, Inc. | 1 | $104 |
| Ipsen Biopharmaceuticals, Inc | 3 | $85 |
| GENZYME CORPORATION | 3 | $77 |
| Regeneron Healthcare Solutions, Inc. | 2 | $72 |
| Verona Pharma, Inc. | 3 | $71 |
| Lilly USA, LLC | 2 | $60 |
Products named: IBSRELA, DUPIXENT, RINVOQ, LINZESS, TREMFYA, INTERSTIM, IQIRVO, Ohtuvayre.
Industry payments across GA — which companies pay providers there.
